<--- Back to Details
First PageDocument Content
Chemistry / Cyclic vomiting syndrome / 5-HT3 antagonist / Lorazepam / Ondansetron / Peptic ulcer / Vomiting / Benzodiazepine / Cannabinoid hyperemesis syndrome / Antiemetics / Medicine / Health
Date: 2013-07-07 23:31:26
Chemistry
Cyclic vomiting syndrome
5-HT3 antagonist
Lorazepam
Ondansetron
Peptic ulcer
Vomiting
Benzodiazepine
Cannabinoid hyperemesis syndrome
Antiemetics
Medicine
Health

Princess Margaret Hospital Perth Western Australia Emergency Department Clinical Guidelines Management Guidelines Emergency Department Princess Margaret Hospital for Children

Add to Reading List

Source URL: kidshealthwa.com

Download Document from Source Website

File Size: 28,24 KB

Share Document on Facebook

Similar Documents

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 1a4Ek - View Document

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 19OCx - View Document

Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella

Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella

DocID: 19AF1 - View Document

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 199Dl - View Document

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 1987o - View Document